vs
CONSUMER PORTFOLIO SERVICES, INC.（CPSS）与REPLIGEN CORP（RGEN）财务数据对比。点击上方公司名可切换其他公司
REPLIGEN CORP的季度营收约是CONSUMER PORTFOLIO SERVICES, INC.的1.8倍（$197.9M vs $109.4M），REPLIGEN CORP净利率更高（6.7% vs 4.6%，领先2.2%），REPLIGEN CORP同比增速更快（13.6% vs 3.9%），CONSUMER PORTFOLIO SERVICES, INC.自由现金流更多（$288.3M vs $17.6M），过去两年REPLIGEN CORP的营收复合增速更高（14.4% vs 9.2%）
Consumer Portfolio Services, Inc.是总部位于美国的专业金融公司，主要面向信用记录有限或信用评分不佳的消费者，与各类汽车经销商合作，提供新车及二手车购买的间接汽车贷款融资及贷后管理服务。
Repligen是一家全球生命科学企业，专注于创新生物工艺技术与系统的研发及商业化，助力提升生物药生产效率。公司1981年成立，总部位于美国马萨诸塞州沃尔瑟姆，于纳斯达克挂牌上市，股票代码RGEN，截至2025年全球员工超1900人，主要服务生物制药领域客户。
CPSS vs RGEN — 直观对比
营收规模更大
RGEN
是对方的1.8倍
$109.4M
营收增速更快
RGEN
高出9.7%
3.9%
净利率更高
RGEN
高出2.2%
4.6%
自由现金流更多
CPSS
多$270.7M
$17.6M
两年增速更快
RGEN
近两年复合增速
9.2%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $109.4M | $197.9M |
| 净利润 | $5.0M | $13.3M |
| 毛利率 | — | 52.5% |
| 营业利润率 | 6.6% | 9.0% |
| 净利率 | 4.6% | 6.7% |
| 营收同比 | 3.9% | 13.6% |
| 净利润同比 | -3.2% | 143.9% |
| 每股收益（稀释后） | $0.21 | $0.24 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CPSSRGEN
| Q4 25 | $109.4M | $197.9M | ||
| Q3 25 | $108.4M | $188.8M | ||
| Q2 25 | $109.8M | $182.4M | ||
| Q1 25 | $106.9M | $169.2M | ||
| Q4 24 | $105.3M | $174.1M | ||
| Q3 24 | $100.6M | $154.9M | ||
| Q2 24 | $95.9M | $154.1M | ||
| Q1 24 | $91.7M | $151.3M |
净利润CPSSRGEN
| Q4 25 | $5.0M | $13.3M | ||
| Q3 25 | $4.9M | $14.9M | ||
| Q2 25 | $4.8M | $14.9M | ||
| Q1 25 | $4.7M | $5.8M | ||
| Q4 24 | $5.1M | $-30.3M | ||
| Q3 24 | $4.8M | $-654.0K | ||
| Q2 24 | $4.7M | $3.3M | ||
| Q1 24 | $4.6M | $2.1M |
毛利率CPSSRGEN
| Q4 25 | — | 52.5% | ||
| Q3 25 | — | 53.2% | ||
| Q2 25 | — | 50.0% | ||
| Q1 25 | — | 53.6% | ||
| Q4 24 | — | 26.1% | ||
| Q3 24 | — | 50.0% | ||
| Q2 24 | — | 49.8% | ||
| Q1 24 | — | 49.5% |
营业利润率CPSSRGEN
| Q4 25 | 6.6% | 9.0% | ||
| Q3 25 | 6.5% | 8.9% | ||
| Q2 25 | 6.3% | 7.6% | ||
| Q1 25 | 6.4% | 3.9% | ||
| Q4 24 | 7.0% | -17.7% | ||
| Q3 24 | 6.8% | -5.1% | ||
| Q2 24 | 7.0% | 1.0% | ||
| Q1 24 | 7.1% | 1.3% |
净利率CPSSRGEN
| Q4 25 | 4.6% | 6.7% | ||
| Q3 25 | 4.5% | 7.9% | ||
| Q2 25 | 4.4% | 8.2% | ||
| Q1 25 | 4.4% | 3.4% | ||
| Q4 24 | 4.9% | -17.4% | ||
| Q3 24 | 4.8% | -0.4% | ||
| Q2 24 | 4.9% | 2.2% | ||
| Q1 24 | 5.0% | 1.4% |
每股收益（稀释后）CPSSRGEN
| Q4 25 | $0.21 | $0.24 | ||
| Q3 25 | $0.20 | $0.26 | ||
| Q2 25 | $0.20 | $0.26 | ||
| Q1 25 | $0.19 | $0.10 | ||
| Q4 24 | $0.21 | $-0.55 | ||
| Q3 24 | $0.20 | $-0.01 | ||
| Q2 24 | $0.19 | $0.06 | ||
| Q1 24 | $0.19 | $0.04 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $6.3M | $767.6M |
| 总债务越低越好 | — | $542.2M |
| 股东权益账面价值 | $309.5M | $2.1B |
| 总资产 | $3.9B | $2.9B |
| 负债/权益比越低杠杆越低 | — | 0.26× |
8季度趋势，按日历期对齐
现金及短期投资CPSSRGEN
| Q4 25 | $6.3M | $767.6M | ||
| Q3 25 | $9.4M | $748.7M | ||
| Q2 25 | $15.8M | $708.9M | ||
| Q1 25 | $29.8M | $697.2M | ||
| Q4 24 | $11.7M | $757.4M | ||
| Q3 24 | $8.1M | $784.0M | ||
| Q2 24 | $9.8M | $809.1M | ||
| Q1 24 | $13.2M | $780.6M |
总债务CPSSRGEN
| Q4 25 | — | $542.2M | ||
| Q3 25 | — | $537.9M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $525.6M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益CPSSRGEN
| Q4 25 | $309.5M | $2.1B | ||
| Q3 25 | $307.6M | $2.1B | ||
| Q2 25 | $303.1M | $2.1B | ||
| Q1 25 | $298.4M | $2.0B | ||
| Q4 24 | $292.8M | $2.0B | ||
| Q3 24 | $285.1M | $2.0B | ||
| Q2 24 | $280.3M | $2.0B | ||
| Q1 24 | $279.1M | $2.0B |
总资产CPSSRGEN
| Q4 25 | $3.9B | $2.9B | ||
| Q3 25 | $3.8B | $2.9B | ||
| Q2 25 | $3.8B | $2.9B | ||
| Q1 25 | $3.7B | $2.9B | ||
| Q4 24 | $3.5B | $2.8B | ||
| Q3 24 | $3.5B | $2.8B | ||
| Q2 24 | $3.3B | $2.9B | ||
| Q1 24 | $3.0B | $2.8B |
负债/权益比CPSSRGEN
| Q4 25 | — | 0.26× | ||
| Q3 25 | — | 0.26× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.27× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $289.0M | $25.7M |
| 自由现金流经营现金流 - 资本支出 | $288.3M | $17.6M |
| 自由现金流率自由现金流/营收 | 263.5% | 8.9% |
| 资本支出强度资本支出/营收 | 0.6% | 4.1% |
| 现金转化率经营现金流/净利润 | 58.02× | 1.93× |
| 过去12个月自由现金流最近4个季度 | $500.9M | $93.9M |
8季度趋势，按日历期对齐
经营现金流CPSSRGEN
| Q4 25 | $289.0M | $25.7M | ||
| Q3 25 | $84.9M | $48.1M | ||
| Q2 25 | $54.5M | $28.6M | ||
| Q1 25 | $73.9M | $15.0M | ||
| Q4 24 | $233.8M | $39.2M | ||
| Q3 24 | $69.8M | $49.3M | ||
| Q2 24 | $43.3M | $42.2M | ||
| Q1 24 | $52.7M | $44.7M |
自由现金流CPSSRGEN
| Q4 25 | $288.3M | $17.6M | ||
| Q3 25 | $84.9M | $43.4M | ||
| Q2 25 | $54.3M | $21.5M | ||
| Q1 25 | $73.4M | $11.4M | ||
| Q4 24 | $233.3M | $33.6M | ||
| Q3 24 | $69.7M | $42.3M | ||
| Q2 24 | $43.1M | $37.4M | ||
| Q1 24 | $52.6M | $36.4M |
自由现金流率CPSSRGEN
| Q4 25 | 263.5% | 8.9% | ||
| Q3 25 | 78.3% | 23.0% | ||
| Q2 25 | 49.5% | 11.8% | ||
| Q1 25 | 68.7% | 6.8% | ||
| Q4 24 | 221.6% | 19.3% | ||
| Q3 24 | 69.3% | 27.3% | ||
| Q2 24 | 45.0% | 24.3% | ||
| Q1 24 | 57.3% | 24.0% |
资本支出强度CPSSRGEN
| Q4 25 | 0.6% | 4.1% | ||
| Q3 25 | 0.0% | 2.5% | ||
| Q2 25 | 0.1% | 3.9% | ||
| Q1 25 | 0.4% | 2.1% | ||
| Q4 24 | 0.4% | 3.2% | ||
| Q3 24 | 0.1% | 4.5% | ||
| Q2 24 | 0.2% | 3.1% | ||
| Q1 24 | 0.1% | 5.5% |
现金转化率CPSSRGEN
| Q4 25 | 58.02× | 1.93× | ||
| Q3 25 | 17.50× | 3.23× | ||
| Q2 25 | 11.35× | 1.92× | ||
| Q1 25 | 15.74× | 2.57× | ||
| Q4 24 | 45.43× | — | ||
| Q3 24 | 14.55× | — | ||
| Q2 24 | 9.27× | 12.70× | ||
| Q1 24 | 11.48× | 21.35× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
